 randomized trial levamisole versus placebo adjuvant therapy malignant melanoma long-term follow-up median years patients randomized trial levamisole versus placebo surgical adjuvant therapy patients malignant melanoma patients levamisole placebo results difference treatment control groups regard end points disease-free interval time appearance visceral metastasis survival significant difference treatment control groups age sex stage disease